3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
8
Neoplasms
2
Prostatic Neoplasms, Castration-Resistant
1
PSMA-positive Metastatic Castration Resistant Prostate Cancer (mCRPC) With Prior Exposure to One Prior ARPI Who Are Candidates for Taxane-based Chemotherapy
1
Neoplasm Metastasis
1
Metastatic Hormone-sensitive Prostate Cancer
1
Metastatic Castration-Resistant Prostate Cancer
1
Colorectal Neoplasms
1
Castrate Sensitive Prostate Cancer
1
Carcinoma, Renal Cell
1
Carcinoma, Hepatocellular
1
Bulbo-Spinal Atrophy, X-Linked
1
Bites and Stings
1
Interventions
Rituximab
12
Biopsy
12
Specimen Handling
11
Cyclophosphamide
11
Magnetic Resonance Spectroscopy
10
obinutuzumab
7
Lenalidomide
7
fludarabine
6
Prednisone
6
pembrolizumab
5
Nuclear Medicine Department, Hospital
5
X-Rays
4
Doxorubicin
4
venetoclax
3
ibrutinib
3
glofitamab
3
fludarabine phosphate
3
acalabrutinib
3
Vincristine
3
Tacrolimus
3
Mycophenolic Acid
3
GSK2636771
3
Etoposide
3
Busulfan
3
Bendamustine Hydrochloride
3
zanubrutinib
2
trametinib
2
tocilizumab
2
palbociclib
2
osimertinib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma
×
abiraterone
×
30 days
×
Clear all
No trials found.